Avian flu chips validated by the U.S. Centers for Disease Control and Prevention (CDC) could soon be showing up at U.S. medical clinics. The "MChip," a microarray which can quickly identify avian flu, will be used to monitor a possible pandemic. It could also be used to streamline clinical laboratory testing. Quidel Corp. (San Diego) holds an exclusive license to manufacture and distribute avian influenza test kits using the patented MChip.
Text: http://www.eetimes.com/showArticle.jhtml?articleID=196801208